-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Neutral on Sabra Health Care REIT, Raises Price Target to $22

Benzinga·11/16/2026 17:58:21
Listen to the news
Mizuho analyst Vikram Malhotra maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Neutral and raises the price target from $21 to $22.